Smith Thomas B
Insider transactions at 1 company
This page shows all SEC Form 4 filings attributed to Smith Thomas B. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.
| Company | Title | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| COLL | EVP and Chief Medical Officer | Sale | 17,478 | $38.42 | $671,505 | Aug 29, 2025 |
| COLL | EVP and Chief Medical Officer | Award / Grant | 33,762 | — | — | Feb 10, 2025 |
| COLL | EVP and Chief Medical Officer | Sale | 9,593 | $36.62 | $351,296 | Sep 13, 2024 |
| COLL | EVP and Chief Medical Officer | Sale | 995 | $36.76 | $36,576 | Feb 29, 2024 |
| COLL | EVP and Chief Medical Officer | Award / Grant | 30,800 | — | — | Feb 12, 2024 |
| COLL | EVP and Chief Medical Officer | Award / Grant | 31,185 | — | — | Feb 10, 2023 |
| 0001103021 | Chief Medical Officer | Other | 52,530 | — | — | Mar 22, 2022 |
| 0001103021 | Chief Medical Officer | Option Exercise | 7,667 | — | — | Jan 31, 2022 |
| 0001103021 | Chief Medical Officer | Option Exercise | 7,667 | — | — | Jan 29, 2021 |
| 0001103021 | Chief Medical Officer | Option Exercise | 7,666 | — | — | Jan 31, 2020 |